Dysregulated Genes, MicroRNAs, Biological Pathways, and Gastrocnemius Muscle Fiber Types Associated With Progression of Peripheral Artery Disease: A Preliminary Analysis

• Published in: Journal of the American Heart Association Vol. 11; no. 21; p. e023085
• Main Authors: Saini, Sunil K., Pérez‐Cremades, Daniel, Cheng, Henry S., Kosmac, Kate, Peterson, Charlotte A, Li, Lingyu, Tian, Lu, Dong, Gengfu, Wu, Kevin K., Bouverat, Brian, Wohlgemuth, Stephanie E., Ryan, Terence, Sufit, Robert L., Ferrucci, Luigi, McDermott, Mary M., Leeuwenburgh, Christiaan, Feinberg, Mark W.
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 01.11.2022; Wiley
• Subjects: differentially expressed genes (DEG); gastrocnemius muscle; Humans; MicroRNAs - genetics; MicroRNAs - metabolism; Muscle Fibers, Skeletal - metabolism; Muscle, Skeletal; Original Research; Peripheral Arterial Disease - diagnosis; Peripheral Arterial Disease - genetics; Peripheral Arterial Disease - metabolism; peripheral artery disease (PAD); RNA, Messenger - metabolism; gastrocnemius muscle; peripheral artery disease (PAD); differentially expressed genes (DEG)
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/JAHA.121.023085

Background Peripheral artery disease (PAD) is associated with gastrocnemius muscle abnormalities. However, the biological pathways associated with gastrocnemius muscle dysfunction and their associations with progression of PAD are largely unknown. This study characterized differential gene and microRNA (miRNA) expression in gastrocnemius biopsies from people without PAD compared with those with PAD. Participants with PAD included those with and without PAD progression. Methods and Results mRNA and miRNA sequencing were performed to identify differentially expressed genes, differentially expressed miRNAs, mRNA-miRNA interactions, and associated biological pathways for 3 sets of comparisons: (1) PAD progression (n=7) versus non-PAD (n=7); (2) PAD no progression (n=6) versus non-PAD; and (3) PAD progression versus PAD no progression. Immunohistochemistry was performed to determine gastrocnemius muscle fiber types and muscle fiber size. Differentially expressed genes and differentially expressed miRNAs were more abundant in the comparison of PAD progression versus non-PAD compared with PAD with versus without progression. Among the top significant cellular pathways in subjects with PAD progression were muscle contraction or development, transforming growth factor-beta, growth/differentiation factor, and activin signaling, inflammation, cellular senescence, and notch signaling. Subjects with PAD progression had increased frequency of smaller Type 2a gastrocnemius muscle fibers in exploratory analyses. Conclusions Humans with PAD progression exhibited greater differences in the number of gene and miRNA expression, biological pathways, and Type 2a muscle fiber size compared with those without PAD. Fewer differences were observed between people with PAD without progression and control patients without PAD. Further study is needed to confirm whether the identified transcripts may serve as potential biomarkers for diagnosis and progression of PAD.